Make parasite protection easy with NexGard® COMBO!
Introducing the first all-in-one monthly topical solution that safeguards against fleas, ticks, mites, heartworm disease, lungworm disease, and intestinal worms including tapeworms.
Make parasite protection easy with NexGard® COMBO!
Introducing the first all-in-one monthly topical solution that safeguards against fleas, ticks, mites, heartworm disease, lungworm disease, and intestinal worms including tapeworms.
Rapidly kill fleas and ticks
Treats and control flea allergy dermatitis (FAD)
Treat ear mites
Prevent heartworms diseases
Treats roundworms, hookworms, vesical worms, and tapeworms
Protection from 8 weeks of age and 0.8kg bodyweight
Safe in pregnant and lactating queens
Prevent and treat lungworms diseases
NexGard® Combo | Brand A (selamectin, sarolaner) | Brand B (imidacloprid, moxidectin) | |
---|---|---|---|
Fleas |
applicable | applicable | applicable |
Ticks |
applicable | applicable | |
Ear mites |
applicable | applicable | applicable |
Roundworms |
applicable | applicable | applicable |
Hookworms |
applicable | applicable | applicable |
Tapeworms |
applicable | ||
Lungworms |
applicable | applicable | |
Heartworms |
applicable | applicable | applicable |
Safety Profile
All medicines, including veterinary medicines, carry benefits and risks. NexGard® COMBO contains the active ingredient esafoxolaner. Esafoxolaner is part of the isoxazoline family of chemicals. Adverse reactions to this family of chemicals are rarely observed but may include vomiting, diarrhoea, lethargy, inappetence (loss of appetite), itching and very rarely, seizures. Most adverse reactions are mild, self-limiting and of short duration. For cats with a history of epilepsy or other seizure disorders, it is recommended to seek veterinary advice prior to treatment with medicines of this class. Eprinomectin and praziquantel are the other active ingredient in NexGard® COMBO. Adverse reactions to eprinomectin and praziquantel are rarely observed at recommended doses.
Rigorous safety studies demonstrate NexGard® COMBO excellent safety profile. This is further supported by Boehringer Ingelheim’s rigorous pharmacovigilance program which closely monitors and evaluates any suspected adverse events reported to the company by pet owners or veterinarians in all countries where the product is registered.
For more information please read the product information leaflets. If you have any questions or concerns about NexGard® COMBO, we encourage you to contact your Veterinarian or Contact Us.